Squamous Cell Carcinoma of the Lung
📧 Sign up to get email alerts when something new happens for Squamous Cell Carcinoma of the Lung.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2019-07-16Clinical Trial Update: Study of Glembatumumab Vedotin in gpNMB-Expressing, Advanced or Metastatic SCC of the Lung [Phase 1, Phase 2]
A clinical trial evaluating Glembatumumab Vedotin in gpNMB-expressing advanced or metastatic squamous cell carcinoma of the lung has been te…
-
CLINICAL_TRIALS trial_result · 2018-11-14Clinical Trial Update: A Study of Atezolizumab Compared With Gemcitabine Plus (+) Cisplatin or Carboplatin for PD-L1-Selected Participants With Stage IV Squamous Non-Small Cell Lung Cancer (NSCLC) (IMpower111) [Phase 3]
Phase 3 IMpower111 trial comparing atezolizumab to gemcitabine plus cisplatin or carboplatin in PD-L1-selected stage IV squamous non-small c…
-
CLINICAL_TRIALS trial_result · 2018-03-21Clinical Trial Update: Pilot Study to Evaluate Optical Frequency Domain Imaging for Diagnosis of Central Airway Disease
This clinical trial update reports a pilot study evaluating Optical Frequency Domain Imaging for diagnosing central airway disease; the tria…
-
CLINICAL_TRIALS trial_result · 2017-06-08Clinical Trial Update: Nintedanib in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Failed Up to Two Previous Chemotherapy Regimens [Phase 2]
Phase 2 trial evaluating nintedanib in patients with advanced non-small cell lung cancer who progressed after up to two prior chemotherapy r…
-
CLINICAL_TRIALS trial_result · 2016-11-02Clinical Trial Update: PEPITA Study: An Observational Study of Tarceva (Erlotinib) in Second Line in Patients With Locally Advanced or Metastatic Squamous Non-Small Cell Lung Cancer
The PEPITA observational study evaluating erlotinib (Tarceva) in second-line squamous non-small cell lung cancer has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2016-10-17Clinical Trial Update: MK2206 and Erlotinib Hydrochloride in Treating Patients With Advanced Non-Small Cell Lung Cancer Who Have Progressed After Previous Response to Erlotinib Hydrochloride Therapy [Phase 2]
Phase 2 study evaluating MK-2206 with erlotinib in advanced non-small cell lung cancer patients who progressed after prior erlotinib; the tr…
-
CLINICAL_TRIALS trial_result · 2016-09-02Clinical Trial Update: A Study of Onartuzumab (MetMAb) Versus Placebo in Combination With Paclitaxel Plus Platinum in Patients With Squamous Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 clinical trial evaluating Onartuzumab (MetMAb) plus paclitaxel and platinum versus placebo in squamous non-small cell lung cancer …
-
CLINICAL_TRIALS trial_result · 2016-08-24Clinical Trial Update: A Study of Avastin (Bevacizumab) in Combination With Platinum-Based Chemotherapy in Patients With Advanced or Recurrent Squamous Non-Small Cell Lung Cancer [Phase 2]
A Phase 2 trial evaluating Avastin (bevacizumab) with platinum-based chemotherapy for advanced or recurrent squamous non-small cell lung can…
-
CLINICAL_TRIALS trial_result · 2016-06-27Clinical Trial Update: First-line Treatment of Participants With Stage IV Squamous Non-Small Cell Lung Cancer With Necitumumab and Gemcitabine-Cisplatin [Phase 3]
Phase 3 trial evaluates first-line treatment with necitumumab plus gemcitabine and cisplatin in stage IV squamous non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2016-06-23Clinical Trial Update: Phase 3 Trial in Squamous Non Small Cell Lung Cancer Subjects Comparing Ipilimumab Versus Placebo in Addition to Paclitaxel and Carboplatin [Phase 3]
Phase 3 trial evaluating ipilimumab plus paclitaxel and carboplatin versus placebo in squamous non-small cell lung cancer; study completed w…
-
CLINICAL_TRIALS trial_result · 2016-04-18Clinical Trial Update: A Study of BIND-014 (Docetaxel Nanoparticles for Injectable Suspension) as Second-line Therapy for Patients With KRAS Positive or Squamous Cell Non-Small Cell Lung Cancer [Phase 2]
Phase 2 study update for BIND-014, a docetaxel nanoparticle formulation, in second-line non-small cell lung cancer (KRAS-positive and squamo…
-
CLINICAL_TRIALS trial_result · 2016-03-31Clinical Trial Update: A Study of REOLYSIN® in Combination With Paclitaxel and Carboplatin in Patients With Squamous Cell Carcinoma of the Lung [Phase 2]
Phase 2 trial evaluating REOLYSIN in combination with paclitaxel and carboplatin for metastatic or recurrent squamous cell carcinoma of the …
-
CLINICAL_TRIALS trial_result · 2015-12-31Clinical Trial Update: Nedaplatin/Docetaxel Versus Cisplatin/Docetaxel in Treatment of Advanced/Relapsed Squamous Cell Lung Cancer [Phase 3]
A Phase 3 study comparing nedaplatin plus docetaxel versus cisplatin plus docetaxel for advanced or relapsed squamous cell lung cancer.
-
CLINICAL_TRIALS trial_result · 2015-01-01Clinical Trial Update: Gefitinib in Treating Patients With Stage IB, II, or IIIA Non-small Cell Lung Cancer That Was Completely Removed by Surgery [Phase 3]
Phase 3 trial evaluating gefitinib after complete surgical removal of stage IB to IIIA non-small cell lung cancer; results were posted in 20…
-
CLINICAL_TRIALS trial_result · 2014-12-31Clinical Trial Update: STUDY OBSERVATIONAL OF ERLOTINIB AS SECOND LINE TREATMENT IN PATIENTS WITH SQUAMOUS NSCLC AND EGFR NATIVE
Observational study evaluating erlotinib as second-line treatment in patients with squamous cell non-small cell lung cancer and wild-type EG…
-
CLINICAL_TRIALS trial_result · 2014-12-23Clinical Trial Update: Ponatinib for Squamous Cell Lung and Head and Neck Cancers [Phase 2, Phase 3]
Ponatinib was studied in Phase 2/Phase 3 trials for squamous cell carcinoma of the lung and head and neck squamous cell carcinoma. The studi…
-
CLINICAL_TRIALS trial_result · 2014-11-21Clinical Trial Update: LUX-Lung 8: A Phase III Trial of Afatinib (BIBW 2992) Versus Erlotinib for the Treatment of Squamous Cell Lung Cancer After at Least One Prior Platinum Based Chemotherapy [Phase 3]
Phase III trial comparing afatinib versus erlotinib in squamous cell non-small cell lung cancer after platinum-based therapy; results comple…
-
CLINICAL_TRIALS trial_result · 2014-11-06Clinical Trial Update: The Comparative Study on Rh-Endostatin (Endostar®) Continuous Intravenous Infusion and Routine i.v in Combination With GP Regimens for Phase III B/IV Squamous Cell Lung Cancer and Biological Markers Exploration. [Phase 3]
A Phase III trial evaluating rh-endostatin (Endostar) given as a continuous IV infusion plus GP chemotherapy versus GP chemotherapy alone in…
-
CLINICAL_TRIALS trial_result · 2014-08-06Clinical Trial Update: Nab-Paclitaxel Treatment in Advanced Squamous Cell Carcinoma of Lung [Phase 2]
This document reports the completion of a Phase 2 trial evaluating Nab-Paclitaxel in advanced squamous cell carcinoma of the lung.
-
CLINICAL_TRIALS trial_result · 2014-07-15Clinical Trial Update: Dasatinib in Advanced Squamous Cell Lung Cancer [Phase 2]
Phase 2 trial of dasatinib in advanced squamous cell carcinoma of the lung was terminated; results have been posted.
-
CLINICAL_TRIALS trial_result · 2014-04-25Clinical Trial Update: Nab-paclitaxel as Second-line Therapy in Locally Advanced or Metastatic Squamous Lung Cancer [Phase 2]
A Phase 2 clinical trial assessing nab-paclitaxel as second-line therapy for locally advanced or metastatic squamous cell carcinoma of the l…
-
CLINICAL_TRIALS trial_result · 2013-12-03Clinical Trial Update: Carboplatin And Paclitaxel With Or Without CP-751, 871 (An IGF-1R Inhibitor) For Advanced NSCLC Of Squamous, Large Cell And Adenosquamous Carcinoma Histology [Phase 3]
A Phase 3 trial evaluating carboplatin and paclitaxel with or without the IGF-1R inhibitor CP-751,871 in advanced non-small cell lung cancer…
-
CLINICAL_TRIALS trial_result · 2013-09-20Clinical Trial Update: Metronomic Cyclophosphamide in Combination With Standard Chemotherapy for Squamous Cell Lung Carcinoma [Phase 3]
A Phase 3 clinical trial update investigating metronomic cyclophosphamide with standard chemotherapy for squamous cell carcinoma of the lung…
-
CLINICAL_TRIALS trial_result · 2013-07-24Clinical Trial Update: Trial Of CP-751, 871 And Erlotinib In Refractory Lung Cancer [Phase 3]
Pfizer-sponsored Phase 3 trial evaluating figitumumab (CP-751,871) with erlotinib in refractory lung cancer was terminated and results were …
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Surgery With or Without Chemotherapy in Treating Patients With Stage I Non-small Cell Lung Cancer [Phase 3]
A Phase 3 trial comparing surgery with and without chemotherapy in patients with Stage I non-small cell lung cancer has completed.